Japanese pharmaceutical company Takeda has announced a strategic partnership with Biological E, a le...
SK bioscience, a South Korea-based vaccine and biotech company, has obtained prequalification (PQ) certification from th...
US-based VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and t...
The 16th Obstetrics and Gynaecology Conference took place on 30 January under the theme ‘From evidence to practice...
GSK Australia has received Therapeutic Goods Administration (TGA) approval of AREXVY (respiratory syncytial virus v...
Singapore-based Zuellig Pharma has announced its commercialisation partnership with French pharmaceutical company Substi...
A team of scientists, led by Singapore’s Duke-NUS Medical School, has discovered a potential intranasal vaccine ca...
Norway-based Coalition for Epidemic Preparedness Innovations(CEPI) has partnered with Lemonex Inc. (Lemonex), a bi...
The International Vaccine Institute (IVI) and EuBiologics Co have announced the licensure for export by the Korean Minis...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and US-based nonprofit global health organisation&nb...
American firm Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, h...
Denmark-based Novo Nordisk Foundation is committing up to DKK 1.8 billion ($260 million) to establish a state-...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with Korea’s Chungbuk National U...
South Korea-based DxVx will conduct its own clinical trials of OVM-200, an anti-cancer vaccine from Oxford Vacmedix (OVM...
Thailand's Chulalongkorn University and the University of Sheffield, England, have signed an academic cooperation agreem...
The International Vaccine Institute (IVI) and the Korea Advanced Institute of Science and Technology (KAIST) have signed...
South Korea-based SK bioscience has entered into a development licensing agreement with Hilleman Laboratories, in Singap...
The University of Hong Kong (HKU), the University of Cambridge (UCAM), and the International Vaccine Institute (IVI) hav...
